EUVIMEDEUVIMED entdecken
Open Access

Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022

Jefferson M Jones iD, Eduard Grebe iD, Isaac Lartey, Mars Stone iD, Bryan R Spencer iD, Akitunde Akinseye, Irene Molina Manrique, Rebecca V Fink iD, Valerie Green, Paula Saa iD, Brad J Biggerstaff iD, Melissa M Coughlin iD und 5 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Jefferson M Jones und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Blood Donors, Antibodies, Viral, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, NCIRD CDC HHS, CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

By the end of 2021 in the United States, spike (S) antibody seroprevalence from coronavirus disease 2019 (COVID-19) vaccination, infection, or both (hybrid immunity) reached over 90%. With high seroprevalence, quantitative antibody concentrations are needed to characterize population immunity. We measured quantitative S antibody concentrations in a national blood donor cohort and evaluated their correlation with protection against infection.

Methods

One blood specimen per quarter in 2022 was tested for quantitative S immunoglobulin G (IgG) and infection-induced (nucleocapsid [N]) total Ig antibodies from a national blood donor cohort of 106 969 people. Median S antibody concentrations were calculated by quarter and by history of vaccination and infection. Among vaccinated donors without N antibodies, protection (measured as 1 minus hazard ratios compared with unvaccinated donors) against N antibody seroconversion was estimated by S antibody concentration. Median S antibody levels were compared using the Kruskal-Wallis tests.

Results

Median S antibody concentrations increased from 1380 binding antibody units (BAU)/mL in quarter 1 of 2022 to 1720 BAU/mL in quarter 4 of 2022. In quarter 4, S antibody levels were lowest in the infection-only group (median, 75 BAU/mL) and higher in the vaccine-only group (median, 1950 BAU/mL) and hybrid immunity group (median, 2550 BAU/mL). Protection against first-time infection increased with higher antibody concentrations; 5010 BAU/mL (95% confidence interval, 4120–6550 BAU/mL) was associated with 50% protection.

Discussion

During 2022, this nationwide study showed mildly increased S IgG concentrations over time among blood donors. Vaccination and hybrid immunity resulted in higher antibody concentrations than infection alone. Higher antibody concentrations were associated with increased protection from infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Blood DonorsAntibodies, ViralSpike Glycoprotein, CoronavirusSARS-CoV-2HumansSeroepidemiologic StudiesUnited StatesMaleFemaleAdultMiddle AgedImmunoglobulin GYoung AdultCOVID-19 VaccinesAgedVaccinationAdolescentBlood Donation

Stichwörter der Autor:innen

SARS-CoV-2correlates of protectionhybrid immunityimmunityvaccination

Substanzen

Antibodies, ViralSpike Glycoprotein, CoronavirusImmunoglobulin Gspike protein, SARS-CoV-2COVID-19 Vaccines

Autor:innen und Institutionen

  • National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Vitalant Research Institute, San Francisco, California, USA.
  • Westat, Rockville, Maryland, USA.
  • Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Scientific Affairs, American Red Cross, Gaithersburg, Maryland, USA.
  • Creative Testing Solutions, Tempe, Arizona, USA.

ORCID-Profile: Jefferson M Jones, Eduard Grebe, Mars Stone, Bryan R Spencer, Rebecca V Fink, Paula Saa, Brad J Biggerstaff, Melissa M Coughlin, Melissa Briggs-Hagen, Jean Opsomer

Förderung

  • Intramural CDC HHS
  • NCIRD CDC HHS
  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Jones, J. M., Grebe, E., Lartey, I., Stone, M., Spencer, B. R., Akinseye, A., Molina Manrique, I., Fink, R. V., Green, V., Saa, P., Biggerstaff, B. J., Coughlin, M. M., Briggs-Hagen, M., Lanteri, M. C., Opsomer, J., Wright, D. J., & Busch, M. P. (2025). Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf329

Vancouver

Jones JM, Grebe E, Lartey I, Stone M, Spencer BR, Akinseye A, et al. Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf329

BibTeX
@article{Jones2025,
  author = {Jones, Jefferson M and Grebe, Eduard and Lartey, Isaac and Stone, Mars and Spencer, Bryan R and Akinseye, Akitunde and Molina Manrique, Irene and Fink, Rebecca V and Green, Valerie and Saa, Paula and Biggerstaff, Brad J and Coughlin, Melissa M and Briggs-Hagen, Melissa and Lanteri, Marion C and Opsomer, Jean and Wright, David J and Busch, Michael P},
  title = {Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf329}
}
Kostenlos starten →